GLYCOSYLATION MARKERS FOR PANCREATITIS, SEPSIS AND PANCREATIC CANCER

摘要

The present invention provides novel biomarkers for use in the diagnosis and prognosis of cancer and chronic inflammation and further of diseases which are mediated by chronic inflammation. The biomarkers are glycoproteins, the levels of which have been correlated by the inventors to correspond to particular disease conditions. The invention further extends to methods for monitoring the response to therapy of a treatment of a cancerous or chronic inflammatory condition.